Lin Liu

TL;DR: The gut microbiome in liver cirrhosis is characterized by comparing 98 patients and 83 healthy control individuals and on the basis of only 15 biomarkers, a highly accurate patient discrimination index is created and validated on an independent cohort, suggesting microbiota-targeted biomarkers may be a powerful tool for diagnosis of different diseases.

TL;DR: The recent expansion of quantitative models addresses many questions regarding tumour initiation, progression and metastases as well as intra-tumour heterogeneity, treatment responses and resistance.

TL;DR: It is suggested that ACT is an effective and acceptable adjunct intervention for patients with chronic pain and cognitive‐behavioral therapy may be more satisfactory.

TL;DR: It is suggested that telomeres lengthen during the early cleavage cycles following fertilization through a recombination-based mechanism, and that from the blastocyst stage onwards, telomerase only maintains the telomere length established by this alternative mechanism.

TL;DR: It is demonstrated that reprogramming restores telomere elongation in DC cells despite genetic lesions affecting telomerase, and it is shown that strategies to increase TERC expression may be therapeutically beneficial in DC patients.